Advertisement

Topics

Latest "Prima-Temp, Inc" News Stories

09:01 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Prima-Temp, Inc" found in our extensive news archives from over 250 global news sources.

More Information about Prima-Temp, Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Prima-Temp, Inc for you to read. Along with our medical data and news we also list Prima-Temp, Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Prima-Temp, Inc Companies for you to search.

Showing "Prima Temp" News Articles 1–25 of 61

Wednesday 17th October 2018

Immutep Ltd IMM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryImmutep Ltd Immutep is formerly known as Prima BioMed Ltd, is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company provide products based on LAG3 immune control mechanism which is active in the regulation of the T cell immune response. It develops IMP701, a blocking antiLAG3 antibody for cancer and is in phase I of...


Friday 12th October 2018

Batter Breader Premixes Market by Application Meat, Seafood, and Vegetables, Batter Type Adhesion, Tempura, Beer, Thick, and Customized, Breader Type Crumbs Flakes and Flour Starch, and Region Global Forecast to 2023 [Report Updated: 27082018] Prices

Batter breader premixes markets projected to grow at CAGRs of 6.0% and 5.3%, respectivelyThe global batter premixes market is estimated at USD 886.6 million in 2018. It is projected to reach USD 1,186.4 million by 2023, at a CAGR of 6.0% from 2018. Furthermore, the global breader premixes market is estimated at USD 430.8 million in 2018. It is projected to reach USD 557.7 million by 2023, at a CA...

Immutep Ltd PRR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryImmutep LtdImmutep is formerly known as Prima BioMed Ltd is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company's products are based on LAG3 immune control mechanism which is active in the regulation of the T cell immune response. It develops IMP701, a blocking antiLAG3 antibody for cancer and is in phase I of its...


Thursday 11th October 2018

Global Paper Clay Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Tuesday 9th October 2018

A 1.5°C vs 2°C world-temp rise could mean fewer health, ecosystem effects, new report finds

There is a new report out from the Intergovernmental Panel on Climate Change (IPCC). The in-depth report’s titl

Monday 8th October 2018

Prima-Temp Has Acquired Kindara, a Fellow Boulder-Based Women’s Healthtech Company

Prima-Temp, a women's healthtech company, has acquired Kindara, another Boulder-based women’s healthtech company. Kindara makes an app and Bluetooth-connected thermometer to help women track their fertility and create a community of other women looking to monitor their health and ovulation. Prima-Temp makes the Priya, a data-tracking medical device inserted inside a woman to continuously mo...

Thursday 4th October 2018

Kanel – nyttigt, farligt eller bara gott?

Idag firas den svenska nationalbullen. Flera miljoner kanelbullar kommer att bakas och ätas idag och bagarna mår prima när det klirrar i kassorna. Men hur mår vi av kanel?

Wednesday 3rd October 2018

Guangdong Biolight Meditech Co Ltd 300246 Medical Equipment Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryGuangdong Biolight Meditech Co Ltd Biolight is a medical device company. The company operates in the business of research, development, production and sale of medical treatment monitors, medical consumables and healthcare solutions. It offers patient monitors, hemodialysis products and home care products. Biolight's patient monitors include fetal monitor, ECG machine, medical pump and veter...

Monday 1st October 2018

Pixium Vision: Total number of voting rights and shares composing the share capital as at September 30, 2018

 Information on total number of voting rights and shares composing the share capital as at September 30, 2018 Paris, October 1st, 2018 - 6.00PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, announces the evolution of its share capital. The ...

Monday 24th September 2018

Pixium Vision: Positive review of the first results with PRIMA, its wireless implant, in patients with atrophic Dry-AMD

 Pixium Vision announces positive review of the first results with PRIMA, its wireless subretinal implant, in patients with atrophic Dry-AMD PRIMA could be safely implanted In all five patients, implants were successfully activated Training helps to improve quality of visual perception Paris, France. September 24, 2018 - 6.00 PM CEST - Pixium Vision (FR0011950641 - PIX),...

Tuesday 18th September 2018

Pixium Vision: presentation of the first clinical results with PRIMA, its wireless implant, in patients with Dry-AMD

 Pixium Vision announces the presentation of the first clinical results with PRIMA, its wireless implant, in patients with atrophic Dry-AMD EURETINA Annual Conference Vienna, Austria 20 - 23 September 2018 Paris, France. September 18, 2018 - 7.00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable pat...

Sunday 16th September 2018

FERTILITÉ MASCULINE : Le port de caleçons associé à de meilleures chances de conception ?

Le port de caleçons associé à de meilleures chances de conception, révèle cette étude transversale d’une équipe du Massachusetts General Hospital (MGH-Boston). Des sous-vêtements serrés pourraient ainsi augmenter la température du scrotum (bourses), ce qui réduirait la production de sperme. Des données présentées dans la revue Human Reproduction, qui ajoutent ce facteur au nombre d...

Wednesday 5th September 2018

CSUN Professor, Actor, Screenwriter and Filmmaker Luciana Lagana Receives Phoenix Body of Work Film Award at Action on Film International Film Festival

Dr. Luciana Lagana has an interesting acting and producing body of work that includes anti-bias feature films. LOS ANGELES (PRWEB) September 05, 2018 CSUN Psychology Professor and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, received the Phoenix Body of Work award at the 2018 Action on Film International Film Festival in Las Vegas. Dr. Luciana has an impressive body of work, which incl...

Tuesday 4th September 2018

Attune Medical Completes Final Close of Series C Raise of over $15 Million to Support Continued Global Adoption of Esophageal Temperature Management Device

Chicago-based medical device firm Attune Medical has completed the final close of its Series C raise, now oversubscribed to total more than $15.5 million. This financing will be used to ensure Attune’s continued revenue growth in the worldwide temperature management market, along with expansion of Attune’s technology into emerging clinical applications...

Monday 3rd September 2018

Pixium Vision : Information on total number of voting rights and shares composing the share capital as at August 31, 2018

 Information on total number of voting rights and shares composing the share capital as at August 31, 2018 Paris, September 3rd, 2018 - 6.00PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, announces the evolution of its share capital. The num...

Sunday 2nd September 2018

Pixium achieves milestone in miniature wireless photovoltaic sub-retinal implant

The French feasibility study with PRIMA is a 36-month, 5-patient clinical study, designed to evaluate the safety and function of the wireless photovoltaic sub-retinal PRIMA chip in eliciting The post Pixium achieves milestone in miniature wireless photovoltaic sub-retinal implant appeared first on Compelo Medical Devices.

Thursday 30th August 2018

Pixium Vision achieves successful activation of its photovoltaic PRIMA implant in all five study patients with Dry Age-related Macular Degeneration

 Pixium Vision achieves successful activation of its photovoltaic PRIMA implant in all five study patients with Dry Age-related Macular Degeneration Paris, France. August 30, 2018 - 7.00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, today...

Wednesday 22nd August 2018

Prima distribuzione dello US*1 Toasted Barrel Finish Bourbon della Michter's in tre anni

LOUISVILLE, Kentucky, 22 agosto 2018 /PRNewswire/ -- La distilleria Michter's, con sede a Louisville, Kentucky, sta distribuendo in modo limitato l'imbottigliamento 2018 del proprio innovativo Read more...

Monday 20th August 2018

Digital Insurance Platform Market by Component Tools and Services, EndUsers Insurance Companies, ThirdParty Administrators and Brokers, and Aggregators, Insurance Application, Deployment Type, Organization Size, and Region Global Forecast to 2023 [Report

The digital insurance platform market is expected to grow at a CAGR of 13.7% during the forecast period.The digital insurance platform market size is expected to grow from USD 86.20 billion in 2018 to USD 164.13 billion by 2023, at a Compound Annual Growth Rate CAGR of 13.7% during the forecast period. The growth in the adoption Internet of Things IoT products, rise in the shift of insurers' focus...

Saturday 18th August 2018

Global Curcumin Market Growth, Trends, Industry Analysis, and Forecast 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The market is expected to reach over USD 85 million by 2023, projecting a healthy CAGR of 12.1% over the forecast period, 20182023. It has high applications in pharmaceutical segment due to its number of healthpromoting effects like antiviral, antiinflammatory, and antifungal properties. Market DynamicsRising consumer health consciousness due to presence of artificial ingredients in food, medicine...

Thursday 9th August 2018

Pixium Vision (PIX) - H118 update reflects continued Prima progress

Edison Investment Research - Pharmaceutical & healthcare - Pixium Vision: Pixium’s Prima sub-retinal wireless implant continues to advance through human feasibility trials. The EU study recently reached full enrolment and a US study is slated to start implantations in Q318. Using a risk-adjusted NPV model, we obtain a pipeline rNPV of €90.6m, vs €77.4m previously. ISIN: FR0011950...

Wednesday 8th August 2018

Clarisonic jumps into the next phase of cleansers

Clarisonic

Saturday 4th August 2018

Immutep Ltd PRR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryImmutep LtdImmutep is formerly known as Prima BioMed Ltd is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company's products are based on LAG3 immune control mechanism which is active in the regulation of the T cell immune response. It develops IMP701, a blocking antiLAG3 antibody for cancer and is in phase I of its...

Wednesday 1st August 2018

Pixium Vision: Information on total number of voting rights and shares composing the share capital as at July 31, 2018

 Information on total number of voting rights and shares composing the share capital as at July 31, 2018 Paris, August 1st, 2018 - 6.00PM CEST - Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, announces the evolution of its share capital. The number of voting ri...

Pixium Vision : Pixium Vision restructures its bond financing facility with Kreos Capital

Pixium Vision restructures its bond financing facility with Kreos Capital Paris, France. August 1st, 2018 - 6.00 PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems for patients who lost their sight to enable them to lead more independent lives, announces the signature of an amendment of its Venture Loan agreement in...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks